HEALTHPEAK PROPERTIES INC (PEAK) Stock Fundamental Analysis

NYSE:PEAK • US42250P1030

17.1 USD
+0.35 (+2.09%)
At close: Mar 1, 2024
17.1 USD
0 (0%)
After Hours: 3/1/2024, 8:04:00 PM
Fundamental Rating

3

PEAK gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 123 industry peers in the Diversified REITs industry. While PEAK is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, PEAK is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • In the past year PEAK was profitable.
  • PEAK had a positive operating cash flow in the past year.
  • In the past 5 years PEAK has always been profitable.
  • PEAK had a positive operating cash flow in each of the past 5 years.
PEAK Yearly Net Income VS EBIT VS OCF VS FCFPEAK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B

1.2 Ratios

  • PEAK has a Return On Assets of 1.94%. This is in the better half of the industry: PEAK outperforms 65.60% of its industry peers.
  • PEAK's Return On Equity of 4.79% is fine compared to the rest of the industry. PEAK outperforms 68.80% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 2.45%, PEAK is in line with its industry, outperforming 47.20% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for PEAK is in line with the industry average of 3.06%.
  • The 3 year average ROIC (2.14%) for PEAK is below the current ROIC(2.45%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.94%
ROE 4.79%
ROIC 2.45%
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
PEAK Yearly ROA, ROE, ROICPEAK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

  • The Profit Margin of PEAK (13.95%) is better than 68.00% of its industry peers.
  • In the last couple of years the Profit Margin of PEAK has declined.
  • PEAK has a Operating Margin (20.53%) which is in line with its industry peers.
  • PEAK's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 59.28%, PEAK is doing worse than 73.60% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PEAK has declined.
Industry RankSector Rank
OM 20.53%
PM (TTM) 13.95%
GM 59.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
PEAK Yearly Profit, Operating, Gross MarginsPEAK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

1

2. Health

2.1 Basic Checks

  • PEAK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for PEAK remains at a similar level compared to 1 year ago.
  • PEAK has a worse debt/assets ratio than last year.
PEAK Yearly Shares OutstandingPEAK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
PEAK Yearly Total Debt VS Total AssetsPEAK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 0.34, we must say that PEAK is in the distress zone and has some risk of bankruptcy.
  • PEAK's Altman-Z score of 0.34 is on the low side compared to the rest of the industry. PEAK is outperformed by 64.80% of its industry peers.
  • PEAK has a debt to FCF ratio of 32.87. This is a negative value and a sign of low solvency as PEAK would need 32.87 years to pay back of all of its debts.
  • PEAK has a Debt to FCF ratio of 32.87. This is comparable to the rest of the industry: PEAK outperforms 52.00% of its industry peers.
  • PEAK has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
  • PEAK's Debt to Equity ratio of 1.08 is in line compared to the rest of the industry. PEAK outperforms 53.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 32.87
Altman-Z 0.34
ROIC/WACC0.37
WACC6.55%
PEAK Yearly LT Debt VS Equity VS FCFPEAK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B 8B

2.3 Liquidity

  • PEAK has a Current Ratio of 0.14. This is a bad value and indicates that PEAK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of PEAK (0.14) is worse than 96.80% of its industry peers.
  • A Quick Ratio of 0.14 indicates that PEAK may have some problems paying its short term obligations.
  • PEAK has a worse Quick ratio (0.14) than 96.80% of its industry peers.
Industry RankSector Rank
Current Ratio 0.14
Quick Ratio 0.14
PEAK Yearly Current Assets VS Current LiabilitesPEAK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

4

3. Growth

3.1 Past

  • The earnings per share for PEAK have decreased strongly by -38.86% in the last year.
  • The earnings per share for PEAK have been decreasing by -23.30% on average. This is quite bad
  • Looking at the last year, PEAK shows a small growth in Revenue. The Revenue has grown by 5.81% in the last year.
  • The Revenue has been growing by 12.86% on average over the past years. This is quite good.
EPS 1Y (TTM)-38.86%
EPS 3Y-12.64%
EPS 5Y-23.3%
EPS Q2Q%1200%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%5.56%

3.2 Future

  • The Earnings Per Share is expected to decrease by -3.48% on average over the next years.
  • The Revenue is expected to grow by 8.55% on average over the next years. This is quite good.
EPS Next Y-30.18%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
EPS Next 5Y-3.48%
Revenue Next Year15.38%
Revenue Next 2Y10.7%
Revenue Next 3Y8.55%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PEAK Yearly Revenue VS EstimatesPEAK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B 2.5B
PEAK Yearly EPS VS EstimatesPEAK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2

2

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 30.54, PEAK can be considered very expensive at the moment.
  • Based on the Price/Earnings ratio, PEAK is valued a bit cheaper than 61.60% of the companies in the same industry.
  • PEAK's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.16.
  • PEAK is valuated quite expensively with a Price/Forward Earnings ratio of 43.73.
  • Based on the Price/Forward Earnings ratio, PEAK is valued a bit cheaper than 65.60% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.10, PEAK is valued quite expensively.
Industry RankSector Rank
PE 30.54
Fwd PE 43.73
PEAK Price Earnings VS Forward Price EarningsPEAK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PEAK is valued a bit cheaper than the industry average as 62.40% of the companies are valued more expensively.
  • PEAK's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 44.73
EV/EBITDA 13.46
PEAK Per share dataPEAK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • PEAK's earnings are expected to decrease with -5.39% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%

5

5. Dividend

5.1 Amount

  • PEAK has a Yearly Dividend Yield of 7.02%, which is a nice return.
  • PEAK's Dividend Yield is a higher than the industry average which is at 6.84.
  • PEAK's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 7.02%

5.2 History

  • The dividend of PEAK decreases each year by -11.76%.
  • PEAK has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)-11.76%
Div Incr Years0
Div Non Decr Years0
PEAK Yearly Dividends per sharePEAK Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

  • PEAK pays out 215.92% of its income as dividend. This is not a sustainable payout ratio.
  • The Dividend Rate of PEAK has been decling, while earnings will also be declining. This means the current dividend is most likely not sustainable.
DP215.92%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
PEAK Yearly Income VS Free CF VS DividendPEAK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B
PEAK Dividend Payout.PEAK Dividend Payout, showing the Payout Ratio.PEAK Dividend Payout.PayoutRetained Earnings

HEALTHPEAK PROPERTIES INC

NYSE:PEAK (3/1/2024, 8:04:00 PM)

After market: 17.1 0 (0%)

17.1

+0.35 (+2.09%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-08
Earnings (Next)N/A
Inst Owners117.78%
Inst Owner Change-2.77%
Ins Owners0.15%
Ins Owner Change0%
Market Cap9.36B
Revenue(TTM)2.18B
Net Income(TTM)304.29M
Analysts78.18
Price Target22.19 (29.77%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.02%
Yearly Dividend1.2
Dividend Growth(5Y)-11.76%
DP215.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.48%
Min EPS beat(2)25.88%
Max EPS beat(2)43.09%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-17.64%
Max EPS beat(4)149.96%
EPS beat(8)6
Avg EPS beat(8)80.62%
EPS beat(12)9
Avg EPS beat(12)65.46%
EPS beat(16)12
Avg EPS beat(16)81.29%
Revenue beat(2)1
Avg Revenue beat(2)-0.5%
Min Revenue beat(2)-1.62%
Max Revenue beat(2)0.62%
Revenue beat(4)1
Avg Revenue beat(4)-0.51%
Min Revenue beat(4)-1.62%
Max Revenue beat(4)0.62%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)3
Avg Revenue beat(12)-1.7%
Revenue beat(16)3
Avg Revenue beat(16)-8.89%
PT rev (1m)-1.34%
PT rev (3m)2.46%
EPS NQ rev (1m)-15.62%
EPS NQ rev (3m)-7.95%
EPS NY rev (1m)-12.55%
EPS NY rev (3m)-6.5%
Revenue NQ rev (1m)-1.28%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)6.65%
Revenue NY rev (3m)16.7%
Valuation
Industry RankSector Rank
PE 30.54
Fwd PE 43.73
P/S 4.29
P/FCF 44.73
P/OCF 9.78
P/B 1.47
P/tB 1.55
EV/EBITDA 13.46
EPS(TTM)0.56
EY3.27%
EPS(NY)0.39
Fwd EY2.29%
FCF(TTM)0.38
FCFY2.24%
OCF(TTM)1.75
OCFY10.22%
SpS3.99
BVpS11.61
TBVpS11.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.94%
ROE 4.79%
ROCE 3.1%
ROIC 2.45%
ROICexc 2.47%
ROICexgc 2.68%
OM 20.53%
PM (TTM) 13.95%
GM 59.28%
FCFM 9.59%
ROA(3y)2.8%
ROA(5y)2.26%
ROE(3y)6.66%
ROE(5y)5.35%
ROIC(3y)2.14%
ROIC(5y)1.89%
ROICexc(3y)2.16%
ROICexc(5y)1.9%
ROICexgc(3y)2.33%
ROICexgc(5y)2.05%
ROCE(3y)2.71%
ROCE(5y)2.39%
ROICexgc growth 3Y28.26%
ROICexgc growth 5Y4.6%
ROICexc growth 3Y28.51%
ROICexc growth 5Y3.28%
OM growth 3Y15.69%
OM growth 5Y-5.54%
PM growth 3Y-17.66%
PM growth 5Y-30.94%
GM growth 3Y4.39%
GM growth 5Y-2.65%
F-Score6
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 32.87
Debt/EBITDA 5.74
Cap/Depr 99.62%
Cap/Sales 34.25%
Interest Coverage 2.38
Cash Conversion 79.85%
Profit Quality 68.75%
Current Ratio 0.14
Quick Ratio 0.14
Altman-Z 0.34
F-Score6
WACC6.55%
ROIC/WACC0.37
Cap/Depr(3y)183.97%
Cap/Depr(5y)234.29%
Cap/Sales(3y)65.04%
Cap/Sales(5y)98.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.86%
EPS 3Y-12.64%
EPS 5Y-23.3%
EPS Q2Q%1200%
EPS Next Y-30.18%
EPS Next 2Y-0.06%
EPS Next 3Y-5.39%
EPS Next 5Y-3.48%
Revenue 1Y (TTM)5.81%
Revenue growth 3Y9.86%
Revenue growth 5Y12.86%
Sales Q2Q%5.56%
Revenue Next Year15.38%
Revenue Next 2Y10.7%
Revenue Next 3Y8.55%
Revenue Next 5YN/A
EBIT growth 1Y13.63%
EBIT growth 3Y27.09%
EBIT growth 5Y6.6%
EBIT Next Year208.15%
EBIT Next 3Y49.06%
EBIT Next 5Y31.97%
FCF growth 1Y249.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.21%
OCF growth 3Y8.03%
OCF growth 5Y2.41%

HEALTHPEAK PROPERTIES INC / PEAK FAQ

Can you provide the ChartMill fundamental rating for HEALTHPEAK PROPERTIES INC?

ChartMill assigns a fundamental rating of 3 / 10 to PEAK.


What is the valuation status of HEALTHPEAK PROPERTIES INC (PEAK) stock?

ChartMill assigns a valuation rating of 2 / 10 to HEALTHPEAK PROPERTIES INC (PEAK). This can be considered as Overvalued.


What is the profitability of PEAK stock?

HEALTHPEAK PROPERTIES INC (PEAK) has a profitability rating of 5 / 10.


What is the earnings growth outlook for HEALTHPEAK PROPERTIES INC?

The Earnings per Share (EPS) of HEALTHPEAK PROPERTIES INC (PEAK) is expected to decline by -30.18% in the next year.


Is the dividend of HEALTHPEAK PROPERTIES INC sustainable?

The dividend rating of HEALTHPEAK PROPERTIES INC (PEAK) is 5 / 10 and the dividend payout ratio is 215.92%.